bioRxiv Science⌕ Search

Biology subjects

Inamdar, M. S.

Publications and source records attributed to Inamdar, M. S..

8 recordsLinked to original sources

A robust, reproducible, accessible and scalable protocol for generating three-dimensional human gastruloids

The rapid rise of stem cell-based human embryo models has reignited interest in studying early human development while offering a promising platform to de-risk drugs. Among these, three-dimensional human gastruloids provide a tractable system to model symmetry breaking, germ layer specification and axial organization. However, existing gastruloid protocols remain expensive, specialized, variable and evaluated in a limited number of human pluripotent stem cell (hPSC) lines, restricting broader adoption. Here, we present a simple, robust, standardized gastruloid protocol achieving greater than 90% elongation efficiency with low inter- and intra-experimental variability, developed primarily in BJNhem20, a well-characterized Indian-origin human embryonic stem cell line. Further, we show that the protocol is applicable in a diverse set of hPSC lines. Using a TBXT (Brachyury)-GFP reporter in BJNhem20, we optimized cell seeding density, induction medium and Wnt activation strength, guided by real-time, quantitative assessment of mesoderm induction and symmetry breaking, allowing precise titration of CHIR99021. Comparative testing identified an in-house "Essential 6" medium formulation as the most consistent condition for robust TBXT induction. Optimization of aggregation density produced reproducible gastruloids with polarized TBXT expression and consistent axial elongation, within 72 hours. Single-cell RNA sequencing of individual gastruloids confirmed high transcriptional reproducibility and conserved lineage clusters, aligned with developmental trajectories. Cell line-specific CHIR99021 titration was sufficient to successfully transfer the optimized protocol to two additional lines, BJNhem19 and RUES2-GLR. This simplified and robust protocol reduces costs and improves accessibility, enabling broader application of stem cell-based human embryo models.

developmental biology↗

TGFβ-dependent upregulation of OCIAD2 is essential for epithelial-to-mesenchymal transition during mesendoderm differentiation

Deciphering mechanisms that govern lineage commitment of human pluripotent stem cells (hPSCs) is essential for optimizing differentiation strategies. Here, we investigated the role of the mitochondrial protein OCIAD2 in hPSC differentiation. We show that OCIAD2 is transiently upregulated during mesendoderm differentiation, in a TGF{beta}/Activin A-dependent manner. OCIAD2 depletion impairs mesendoderm induction and specification, resulting in an incomplete epithelial-to-mesenchymal transition (EMT). Through transcriptome analysis, immunoblotting and localization studies on OCIAD2-depleted (KO) or overexpressing (OV) human embryonic stem cells (hESCs), we identified OCIAD2 as a positive regulator of TGF{beta} signalling. Additionally, KO hESCs exhibited downregulated fatty acid oxidation (FAO) genes, indicating dysregulated lipid metabolism. Pharmacological restoration of FAO improved mesendoderm differentiation capacity in KO, suggesting a key role for OCIAD2 in coordinating metabolism and TGF{beta} signalling. We propose that OCIAD2 regulates EMT by integrating metabolic cues with TGF{beta} pathway activation. Our findings provide insight into how mitochondrial proteins regulate lineage commitment and EMT, with broader implications for both developmental biology and tumor progression. HighlightsO_LIOCIAD2 expression peaks during mesendoderm specification of hESCs C_LIO_LIOCIAD2 depletion transcriptionally represses TGF{beta} signalling and impedes EMT C_LIO_LILoss of OCIAD2 leads to hyperfused mitochondria and downregulation of FAO genes C_LIO_LIPharmacologic supplementation with acetate enhances mesendoderm specification C_LI

developmental biology↗

Mitochondrial activity-driven hematopoietic stem cell fate and lympho-myeloid lineage choice is first established in the aorta-gonad-mesonephros

Mitochondrial metabolism determines bone marrow hematopoietic stem cell (HSC) heterogeneity and influences long-term repopulation potential. However, the origin of this heterogeneity and how it regulates HSC phenotype is unclear. We show that during the endothelial-to-hematopoietic transition (EHT) in the mouse embryo, dynamic changes in mitochondrial activity drive the production of mature HSCs with differing potencies. Lowering mitochondrial activity in the AGM by pharmacological or genetic means activates Wnt signaling to promote HSC expansion. Further, mitochondrial membrane potential (MMP) gives rise to functional heterogeneity in the definitive HSC pool. In-vitro and in-vivo functional assays, and single-cell transcriptomics on AGM HSCs showed that MMPlow HSCs are myeloid-biased, with enhanced differentiation potential, while MMPhigh HSCs are lymphoid-biased with diminished differentiation potential. Mechanistically, low mitochondrial activity upregulates Phosphoinositide 3-kinase (PI3K) signaling to promote HSC differentiation. These insights into the initiation of metabolic heterogeneity could be leveraged to isolate HSCs to efficiently generate desired lineages. HighlightsO_LIMitochondrial changes from HSC emergence to maturation govern embryonic hematopoiesis. C_LIO_LILowering mitochondrial activity promotes Wnt-dependent HSC expansion and PI3K-dependent differentiation. C_LIO_LIMitochondrial membrane potential determines lympho-myeloid fate choice in AGM HSCs. C_LIO_LIAberrant mitochondrial activity in the AGM HSCs perturbs adult hematopoiesis. C_LI O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=81 SRC="FIGDIR/small/609550v1_ufig1.gif" ALT="Figure 1"> View larger version (21K): org.highwire.dtl.DTLVardef@10ba1e2org.highwire.dtl.DTLVardef@b10b53org.highwire.dtl.DTLVardef@15eaad0org.highwire.dtl.DTLVardef@2077d5_HPS_FORMAT_FIGEXP M_FIG C_FIG

developmental biology↗

Asrij/OCIAD1 depletion reduces inflammatory microglial activation and ameliorates Aβ pathology in an Alzheimer's disease mouse model

BackgroundAlzheimers disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid-beta (A{beta}) plaques and neurofibrillary tangles, neuroinflammation, and glial activation. Asrij/OCIAD1 (Ovarian Carcinoma Immunoreactive Antigen Domain containing protein 1) is an AD-associated factor. Increased Asrij levels in the brains of AD patients and mouse models are linked to the severity of neurodegeneration. However, the contribution of Asrij to AD progression and whether reducing Asrij levels is sufficient to mitigate A{beta} pathology in vivo is unclear. MethodsTo explore the impact of Asrij on AD pathology, we deleted asrij in the APP/PS1 mouse model of AD and analyzed the effects on AD hallmarks. We used the Morris water maze and open field test to assess behavioral performance. Using immunohistochemistry and biochemical analyses, we evaluated A{beta} plaque load, neuronal and synaptic damage, and gliosis. Further, we utilized confocal microscopy imaging, flow cytometry and RNA sequencing analysis to comprehensively investigate changes in microglial responses to A{beta} pathology upon Asrij depletion. ResultsAsrij depletion ameliorates cognitive impairments, A{beta} deposition, neuronal and synaptic damage, and reactive astrogliosis in the AD mouse. Notably, Asrij-deficient microglia exhibit reduced plaque-associated proliferation and decreased phagocytic activation. Transcriptomic analyses of AD microglia reveal upregulation of energy metabolism pathways and downregulation of innate immunity and inflammatory pathways upon Asrij depletion. Mechanistically, loss of Asrij increases mitochondrial activity and impedes the acquisition of a pro-inflammatory disease-associated microglia (DAM) state. Reduced levels of pro-inflammatory cytokines and decreased STAT3 and NF-{kappa}B activation indicate protective changes in AD microglia. Taken together, our results suggest that increased Asrij levels reported in AD, may suppress microglial metabolic activity and promote inflammatory microglial activation, thereby exacerbating AD pathology. ConclusionsIn summary, we show that Asrij depletion ameliorates A{beta} pathology, neuronal and synaptic damage, gliosis, and improves behavioral performance in APP/PS1 mice. This supports that Asrij exacerbates the AD pathology. Mechanistically, Asrij is critical for the development of DAM and promotes neuroinflammatory signaling activation in microglia, thus restricting neuroprotective microglial responses. Hence, reducing Asrij in this context may help retard AD. Our work positions Asrij as a critical molecular regulator that links microglial dysfunction to AD pathogenesis. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=199 SRC="FIGDIR/small/608066v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@119ae27org.highwire.dtl.DTLVardef@f8c3a1org.highwire.dtl.DTLVardef@1f3b7f2org.highwire.dtl.DTLVardef@1b17805_HPS_FORMAT_FIGEXP M_FIG C_FIG

neuroscience↗

Rudhira-mediated microtubule stability controls TGFβ signaling during mouse vascular development

The Transforming Growth Factor {beta} (TGF{beta}) signaling pathway is critical for survival, proliferation, and cell migration, and is tightly regulated during cardiovascular development. Smads, key effectors of TGF{beta} signaling, are sequestered by microtubules (MTs) and need to be released for pathway function. Independently, TGF{beta} signaling also stabilizes MTs. Molecular details and the in vivo relevance of this cross-regulation remain unclear, understanding which is important in complex biological processes such as cardiovascular development. Here, we use rudhira/Breast Carcinoma Amplified Sequence 3 (BCAS3), a MT-associated, endothelium-restricted and developmentally essential proto-oncogene, as a pivot to decipher cellular mechanisms in bridging TGF{beta} signaling and MT stability. We show that Rudhira regulates TGF{beta} signaling in vivo, during mouse cardiovascular development, and in endothelial cells in culture. Rudhira associates with MTs and is essential for the activation and release of Smad2/3 from MTs. Consequently, Rudhira depletion attenuates Smad2/3- dependent TGF{beta} signaling thereby impairing cell migration. Interestingly, Rudhira is also a transcriptional target of Smad2/3-dependent TGF{beta} signaling essential for TGF{beta}-induced MT stability. Our study identifies an immediate early physical role and a slower, transcription-dependent role for Rudhira in cytoskeleton-TGF{beta} signaling crosstalk. These two phases of control could facilitate temporally-and spatially restricted targeting of the cytoskeleton and/or TGF{beta} signaling in vascular development and disease. Significance statementThe developmental TGF{beta} pathway is essential for cell migration, cell-cell communication, adhesion, apoptosis, and matrix remodeling. Dysregulation of TGF{beta} signaling leads to aberrant vascular patterning and angiogenesis during mouse embryogenesis. Pathway activation involves phosphorylation and nuclear transport of Smads. Microtubules sequester Smads in the cytoplasm, thereby inhibiting TGF{beta} signaling. Conversely, TGF{beta} signaling stabilizes microtubules. However, the molecular components involved, and biological relevance of this cross-regulation remain unclear. We show that the oncoprotein Rudhira/BCAS3 facilitates Smad-MT dissociation upon ligand-mediated TGF{beta} receptor activation. Interestingly, Smad-dependent TGF{beta} signaling activation enhances rudhira transcription, essential for microtubule stabilization during cardiovascular development. This dual regulation of TGF{beta} signaling and microtubule stability by Rudhira allows sustained temporal control essential for development, and its dysregulation has pathological outcomes.

cell biology↗

Charting ESCRT function reveals distinct and non-compensatory roles in blood progenitor maintenance and lineage choice in Drosophila

Most hematological malignancies are associated with reduced expression of one or more components of the Endosomal Sorting Complex Required for Transport (ESCRT). However, the roles of ESCRT in stem cell and progenitor maintenance are not resolved. The difficulty in parsing signaling pathway roles in relation to their canonical cargo sorting function poses a challenge. The Drosophila hematopoietic organ, the larval lymph gland, provides a path to dissect the roles of cellular trafficking pathways such as ESCRT in blood development and maintenance. Drosophila has 13 core ESCRT components. Knockdown of individual ESCRTs showed that only Vps28 and Vp36 were required in all lymph gland progenitors. Using the well-conserved ESCRT-II complex (Vps22, Vps25 and Vps36) as an example of the range of phenotypes seen upon ESCRT depletion, we show that ESCRTs have cell autonomous as well as non-autonomous roles in progenitor maintenance and differentiation. ESCRT depletion also sensitized posterior lymph gland progenitors to respond to immunogenic cues such as wasp infestation. We also identify key heterotypic roles for ESCRT in position-dependent control of Notch activation to suppress crystal cell differentiation. Our study shows that the cargo sorting machinery can determine progenitor identity and capacity to adapt to the dynamic environments that blood cells are exposed to. These mechanisms for control of cell fate may tailor developmental diversity in multiple contexts.

developmental biology↗

Differential activation of JAK-STAT signaling in blood cell progenitors reveals functional compartmentalization of the Drosophila lymph gland.

Blood cells arise from diverse pools of stem and progenitor cells. Understanding progenitor heterogeneity is a major challenge. The Drosophila larval lymph gland is a well-studied model to understand blood progenitor maintenance and recapitulates several aspects of vertebrate hematopoiesis. However in-depth analysis has focused on progenitors located in lymph gland anterior lobes (AP), ignoring the progenitors from the posterior lobes (PP). Using in situ expression mapping and transcriptome analysis we reveal PP heterogeneity and identify molecular-genetic tools to study this abundant progenitor population. Functional analysis shows that PP resist differentiation upon immune challenge, in a JAK-STAT-dependent manner. Upon wasp parasitism, AP downregulate JAK-STAT signaling and form lamellocytes. In contrast, we show that PP activate STAT92E and remain undifferentiated. Stat92E knockdown in PP or genetically reducing JAK-STAT signaling permits PP lamellocyte differentiation. We discuss how heterogeneity and compartmentalization allow functional segregation in response to systemic cues and could be widely applicable. HighlightsWe provide an in situ and transcriptome map of larval blood progenitors Posterior lymph gland progenitors are refractory to immune challenge STAT activation after wasp parasitism maintains posterior progenitors

developmental biology↗

Rudhira/BCAS3 couples microtubules and intermediate filaments to promote cell migration for angiogenic remodeling

Blood vessel formation requires endothelial cell (EC) migration that depends on dynamic remodeling of the cytoskeleton. Rudhira/Breast Carcinoma Amplified Sequence 3 (BCAS3) is a cytoskeletal protein essential for EC migration and sprouting angiogenesis during mouse development and implicated in metastatic disease. Here, we report that Rudhira mediates cytoskeleton organization and dynamics during EC migration. Rudhira binds to both microtubules and Vimentin intermediate filaments (IFs) and stabilizes microtubules. Rudhira depletion impairs cytoskeletal crosstalk, microtubule stability and hence focal adhesion disassembly. The BCAS3 domain of Rudhira is necessary and sufficient for microtubule-IF crosslinking and cell migration. Pharmacologically restoring microtubule stability rescues gross cytoskeleton organization and angiogenic sprouting in Rudhira depleted cells. Our study identifies the novel and essential role of Rudhira in cytoskeletal crosstalk and assigns function to the conserved BCAS3 domain. Targeting Rudhira could allow tissue-restricted cytoskeleton modulation to control cell migration and angiogenesis in development and disease.

molecular biology↗